Navigation Links
Discovery could help to develop drugs for organ transplant and cancer patients
Date:4/13/2012

MAYWOOD, Ill. -- Loyola researchers are reporting surprising findings about a molecule that helps ramp up the immune system in some cases and suppress it in others.

The finding eventually could lead to new drugs to regulate the immune system by, for example, revving it up to attack tumor cells or tamping it down to prevent the rejection of transplanted organs.

The study is published online ahead of print in the Journal of Immunology. Senior author is Makio Iwashima, PhD, an associate professor in the Department of Microbiology & Immunology of Loyola University Chicago Stritch School of Medicine. Co-authors are Robert Love, MD, a professor in the Departments of Thoracic & Cardiovascular Surgery and Microbiology & Immunology and one of the world's leading lung transplant surgeons, and first author Mariko Takami, PhD, of the Department of Microbiology & Immunology.

The immune system relies on a balancing act between two types of cells. Effector cells attack tumor cells and cells infected by viruses or bacteria. Regulatory cells suppress the immune system so that it does not attack healthy tissue. If effector cells are too active, an individual can suffer autoimmune disorders such as lupus, Type 1 diabetes and multiple sclerosis. But if regulatory cells are too active, the immune system will not be aggressive enough to protect the individual from germs and cancer.

The study involved an immune system molecule called transforming growth factor beta (TGF-β). TGF-β is known to be a powerful regulator of the immune response -- generally suppressing the strength of the response. In this study, however, Loyola researchers demonstrated that TGF-β can amplify the immune response and result in a more effective targeted response under specific conditions.

"TGF-β is a double-edged sword," Iwashima said. "It augments immune system reactions but does not determine what direction they will take. Depending on conditions, these reactions can either activate or suppress the immune system."

The study involved mouse cells grown ex vivo in laboratory dishes. The next steps will be to study TGF-β in human cells and in animal models. Understanding the dual role of TGF-β could help in the development of drugs to either activate or suppress the immune system, as needed, Iwashima said.


'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Related medicine news :

1. Washingtons Life Sciences Discovery Fund awards commercialization grants
2. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
3. New discovery of proteins involved in positioning muscular nuclei
4. Cell signaling discovery provides new hope for blood disorders
5. Gene mutation discovery sparks hope for effective endometriosis screening
6. Discovery predicts patient sensitivity to important drug target in deadly brain cancer
7. Discovery of new vaccine approach for treatment of cancer
8. Zebrafish may help speed drug discovery
9. Unexpected discovery opens up new opportunities for targeting cancer
10. Journal names discovery that HIV treatment can prevent spread breakthrough of the year
11. Salk discovery may lead to safer treatments for asthma, allergies and arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2018)... , ... December 05, 2018 , ... ... Wellness and Recovery , has been reappointed to serve on Philadelphia Mayor James ... that support inclusion of those who identify with a cognitive or physical disability. ...
(Date:12/5/2018)... ... ... Marking its seventh year, Pacifica Graduate Institute Alumni Association (PGIAA) ... on New Year’s Eve. Each year event organizer and Director of Alumni Relations ... families, and friends of the institution) to join the celebration. , At ...
(Date:12/5/2018)... SAN DIEGO (PRWEB) , ... December 05, 2018 , ... ... on the field of nursing. Available starting today and on a weekly rolling basis ... Doctor of Nursing Practice in Executive Leadership (DNP) will prepare degree candidates ...
(Date:12/5/2018)... , ... December 05, 2018 , ... ... reinforces the theme of Unitek’s transformative conference at the DoubleTree Hilton Hotel in ... LL (AAN), Distinguished Professor and Founder/Director of Watson Caring Science Institute, participants and ...
(Date:11/29/2018)... ... ... “The total demand for technologies used in drug discovery reached approximately $4.9 ... “We project the market will grow at a healthy annual rate of 6.4% over ... population ages.” , This report details market activity in the areas of chromatography, sequencing, ...
Breaking Medicine News(10 mins):
(Date:11/29/2018)... ... November 29, 2018 , ... ... announced today the launch of the Annatto-E™ product line, containing unique and natural ... by clinical research, DFH’s new Annatto-E™ products are available in three dosages of ...
(Date:11/29/2018)... ... November 29, 2018 , ... Windsor Gardens Healthcare Center of the Valley ... CA, announced today they were selected by the California Association of Health Facilities (CAHF) ... Engagement Project. , The California Department of Public Health awarded a grant of ...
(Date:11/29/2018)... ... 29, 2018 , ... Access today announced that ... forms and eSignatures functionality accessible via tablets, smartphones, and other portable devices. ... space and it’s about time hospital solutions caught up,” said Access founder and ...
Breaking Medicine Technology: